ized with a vanA probe (5), which was a kind gift from P. Courvalin of the Pasteur Institute, Paris, France. The transferability of the vancomycin resistance of FN1 was examined between the donor strain FN1 and the recipient strain E. faecalis FA2-2 (Rif r Fus r ) and between FN1 and E. faecium KTRF (Rif r Fus r ) by filter-mating experiments. No vancomycin-resistant transconjugants were isolated (frequencies were less than 10 Ϫ7 per donor cell) in mating experiments. Vancomycin-resistant E. faecium was not identified in stool samples from the patient or from other patients who were hospitalized in the same room. The patient had never received vancomycin chemotherapy. Although the reservoir and mode of infection of the vancomycin-resistant E. faecium was not determined in this case, E. faecium FN1 was the first case of high-level vancomycin-resistant enterococci with a class A phenotype isolated from a human in Japan.
This work was supported by a grant for the study of drug-resistant bacteria funded by the Ministry of Health and Welfare, Tokyo, Japan, in 1996 and by a grant from the Ohyama Health Foundation, Inc., Tokyo, Japan.
We thank P. Courvalin for providing the M13-vanA probe and E. Kamei for helpful advice on the manuscript.
